Tech Company Financing Transactions
Precigen Funding Round
On 9/3/2025, Precigen raised $125 million in funding from Pharmakon Advisors.
Transaction Overview
Company Name
Announced On
9/3/2025
Transaction Type
Venture Equity
Amount
$125,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Germantown, MD Undisclosed
USA
Germantown, MD Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Precigen is a biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult-to-treat diseases with high unmet patient need. Precigen is dedicated to advancing scientific breakthroughs from proof-of-concept through commercialization.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Helen Sabzevari
Browse more venture capital transactions:
Prev: 9/3/2025: Mistral AI venture capital transaction
Next: 9/3/2025: Sierra venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs